SEC Form 4Coverage since May 29, 2026
$ANTX insider trading
Over the last 12 months, AN2 Therapeutics insiders reported no purchases and 2 sales totaling $26K across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $26K 2 events
- Events · 12m
- 2 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $ANTX · 12Mvia TradingView
Top insiders · 12m
Williams Sarah JoannePrincipal Accounting Officer1× · $1K
Eizen Joshua MSee Remarks1× · $25K
All insider trades
2 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | Eizen Joshua MSee Remarks · O | ▼ Sale | 5,945 | $4.17 | $25K | -2.8% | — |
| May 29, 2026 | Williams Sarah JoannePrincipal Accounting Officer · O | ▼ Sale | 265 | $4.43 | $1K | -0.4% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ANTX feed.